Literature DB >> 9767432

Cross-linking of Fc(gamma)-receptor on monocytes inhibits hepatitis C virus-specific cytotoxic T-lymphocyte induction in vitro.

T Kanto1, N Hayashi, T Takehara, K Katayama, A Ito, K Mochizuki, N Kuzushita, T Tatsumi, Y Sasaki, A Kasahara, M Hori.   

Abstract

In hepatitis C virus (HCV) infection, immune complex (IC)-type virus particles are frequently observed in circulation. The IC leads to cross-linking of Fcgamma receptors (FcgammaR) on monocytes and exerts immunoinhibitory function. To test the roles of IC in HCV-specific cytotoxic T lymphocyte (CTL) induction, we generated HCV CTL from peripheral blood mononuclear cells of chronic hepatitis C patients with or without HCV-IC- or immunoglobulin G (IgG)-coated culture plates and compared their lytic activities. HCV-IC or adherent IgG, which induces FcgammaR cross-linking, significantly reduced CTL activity. Expression of B7-1 on monocytes decreased on adherent IgG. In addition, tumour necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta1 (TGF-beta1) production increased from cells on adherent IgG and their mRNA expression in monocytes was enhanced. Anti-TNF-alpha antibody during induction on adherent IgG inhibited lysis; however, anti-TGF-beta completely reversed its inhibitory effect. These results demonstrated that HCV-IC or adherent IgG impaired HCV-CTL induction in vitro. The FcgammaR-mediated CTL suppression occurred via decreased expression of monocyte B7-1 and/or enhanced production of TGF-beta1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767432      PMCID: PMC1364222          DOI: 10.1046/j.1365-2567.1998.00538.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells.

Authors:  L Gorelik; Y Bar-Dagan; M B Mokyr
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

2.  Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes.

Authors:  I Esparza; R Green; R D Schreiber
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

3.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

4.  Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.

Authors:  T Kanto; N Hayashi; T Takehara; K Katayama; M Kato; M Akiyama; A Kasahara; H Fusamoto; T Kamada
Journal:  J Med Virol       Date:  1996-10       Impact factor: 2.327

5.  B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors.

Authors:  S Guerder; S R Carding; R A Flavell
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

6.  HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.

Authors:  M J Koziel; D Dudley; N Afdhal; A Grakoui; C M Rice; Q L Choo; M Houghton; B D Walker
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes.

Authors:  J M Debets; C J Van der Linden; I E Dieteren; J F Leeuwenberg; W A Buurman
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

8.  Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro.

Authors:  M C Gagliardi; G De Petrillo; S Salemi; L Boffa; M G Longobardi; P Dellabona; G Casorati; N Tanigaki; R Harris; A Lanzavecchia
Journal:  Int Immunol       Date:  1995-11       Impact factor: 4.823

9.  Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.

Authors:  G Leroux-Roels; C A Esquivel; R DeLeys; L Stuyver; A Elewaut; J Philippé; I Desombere; J Paradijs; G Maertens
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

10.  Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence.

Authors:  T Kanto; N Hayashi; T Takehara; H Hagiwara; E Mita; M Naito; A Kasahara; H Fusamoto; T Kamada
Journal:  J Hepatol       Date:  1995-04       Impact factor: 25.083

View more
  4 in total

1.  Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

Authors:  J Nattermann; G Feldmann; G Ahlenstiel; B Langhans; T Sauerbruch; U Spengler
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

2.  Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions.

Authors:  Laurence U Buxbaum; Phillip Scott
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.

Authors:  Janardan P Pandey; Jacquie Astemborski; David L Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Interaction of immune complexes isolated from hepatitis C virus-infected individuals with human cell lines.

Authors:  Rafael Marino; Leopoldo Deibis; Juan B De Sanctis; Nicolas E Bianco; Felix Toro
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.